The met Proto-Oncogene Receptor and Lumen Formation-Reference-Cited by-同舟云学术

The met Proto-Oncogene Receptor and Lumen Formation

Published:1992-08-28 Issue:5074 Volume:257 Page:1258-1261
ISSN:0036-8075
Container-title:Science
language:en
Short-container-title:Science

Author:

Tsarfaty Ilan¹,Resau James H.²,Rulong Shen¹,Keydar Iafa³,Faletto Donna L.¹,Vande Woude George F.¹

Affiliation:

1. ABL-Basic Research Program, National Cancer Institute-Frederick Cancer Research and Development Center, Frederick, MD 21702.

2. National Cancer Institute, Laboratory of Molecular Oncology, Division of Cancer Etiology; Department of Pathology, School of Medicine, University of Maryland, Baltimore, MD 21201.

3. Department of Cell Research and Immunology, Tel Aviv University, Tel Aviv, 69978, Israel.

Publisher

American Association for the Advancement of Science (AAAS)

Subject

Multidisciplinary

Reference35 articles.

1. BASLER, K, UBIQUITOUS EXPRESSION OF SEVENLESS - POSITION-DEPENDENT SPECIFICATION OF CELL FATE, SCIENCE 243: 931 (1989).

2. BIECHE, I, LOSS OF HETEROZYGOSITY ON CHROMOSOME-7Q AND AGGRESSIVE PRIMARY BREAST-CANCER, LANCET 339: 139 (1992).

3. Bissell, M. J., The Mammary Gland: 97 (1987).

4. Identification of the Hepatocyte Growth Factor Receptor As the c- met Proto-Oncogene Product

5. BOWTELL, DDL, OMMATIDIA IN THE DEVELOPING DROSOPHILA EYE REQUIRE AND CAN RESPOND TO SEVENLESS FOR ONLY A RESTRICTED PERIOD, CELL 56: 931 (1989).

Cited by 245 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. Cell Surface Markers and their Targeted Drugs in Breast Cancer;Current Protein & Peptide Science;2022-05

2. A common MET polymorphism harnesses HER2 signaling to drive aggressive squamous cell carcinoma;Nature Communications;2020-03-25

3. Isoquercitrin, ingredients in Tetrastigma hemsleyanum Diels et Gilg, inhibits hepatocyte growth factor/scatter factor-induced tumor cell migration and invasion;Cell Adhesion & Migration;2018-05-28

4. ABBV-399, a c-Met Antibody–Drug Conjugate that Targets Both MET–Amplified and c-Met–Overexpressing Tumors, Irrespective of MET Pathway Dependence;Clinical Cancer Research;2016-08-29

5. ‘Biogeneric’ developmental processes: drivers of major transitions in animal evolution;Philosophical Transactions of the Royal Society B: Biological Sciences;2016-08-19